Login

Luke H Chao, Ph.D. Assistant Professor of Genetics, HMS | The Molecules that Determine Cell Shape 00:00:00

Share On Facebook Share On Twitter

Changing our understanding of life through team science

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Interview with Hans Wallenstam, CEO of Wallenstam | Hans Wallenstam, CEO, Wallenstam AB.
00:10:00
Unlocking Potential: Noront Resources Ltd. | Alan Coutts - CEO of Noront Resources.
00:10:00
Chris Evans Unveils Goulamina Lithium Project's Path to Success in Mali
00:10:00
Ben McMillan, founder and CIO of IDX Digital Assets, discusses the key factors driving the crypto market in an interview with CNBC Crypto World.
00:10:00
Pro Vyx: Enhancing Safety and Productivity with Customized Camera Systems
00:10:00
South Africa's History: From Boer Wars to Present Geopolitics|Thula Simpson,Professor,University of Pretoria
00:10:00
Orvana's assets consist of the producing El Valle and Carlés gold-copper-silver mines in northern Spain and the Don Mario gold-silver property in Bolivia| Juan Gavidia, President and CEO of Orvana Minerals Corp
00:10:00
Old Mutual Launches 2023 Savings and Investment Monitor | Iain Williamson, CEO , Old Mutual Limited.
00:10:00
American Lithium Explores New Frontiers in Lithium Discovery at One-to-One Mining Investment Sydney Event
00:10:00
GCo and TTI: Integrated Operations and Market Insights
00:10:00
Introduction to Weiss Financial Group: Personalized Financial Planning & Investment Management
00:10:00
Tristram Leach serves as the Co-Head of European Credit at Apollo Global Management LLC.|Mr. Rowan is a Co-Founder and CEO of Apollo Global Management, Inc

© 2026 Nehu